| Guidelines for heparin shortage (article here)
Enoxaparin (Clexane) is the safest, most effective form of heparin
available. In the event of unexpected short-fall in supplies, the TGA
should not be recommending second-rate forms of heparin or, worse still,
warfarin during the active phase of thrombosis or for hip surgery
thromboprophylaxis.
Fondaparinux is a synthetic heparinoid which is proven to be safe and
effective. It is superior to enoxaparin for thromboprophylaxis in
association with hip surgery and hip fracture. It is superior to
dalteparin for thromboprophylaxis in association with abdominal surgery. It
is equivalent to Clexane in treatment of DVT and unfractionated heparin in
treatment of pulmonary embolism (MIMS Full Prescribing Information).
Why was fondaparinux not given a big push in these guidelines?
Simple: it is a lot more expensive than the others. But as it is
synthetic, so the factories can easily up-scale their production rates and save
us a repeat of this regrettable incident. This is an opportunity for the
Australian government to negotiate affordable, long-term supplies of a good
anticoagulant. Let’s try, shall we?
Steve Flecknoe-Brown
Haematologist
|
Submit your feedback here: